Yumanity Therapeutics
www.kinetabio.comKineta completed a reverse merger with Yumanity Therapeutics with Kineta, Inc. as the surviving company effective December 19, 2022.
Read more
Kineta completed a reverse merger with Yumanity Therapeutics with Kineta, Inc. as the surviving company effective December 19, 2022.
Read more
Country
State
Massachusetts
City (Headquarters)
Boston
Industry
Employees
11-50
Founded
2014
Estimated Revenue
$1 to $1,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Vice President Finance
Email ****** @****.comPhone (***) ****-****Chairman
Email ****** @****.comPhone (***) ****-****Board Member and Audit Committee Chair
Email ****** @****.comPhone (***) ****-****Vice President and Head of Drug Discovery
Email ****** @****.comPhone (***) ****-****
Technologies
(24)
Reach decision makers at Yumanity Therapeutics
Free credits every month!
Yumanity Therapeutics FAQ
Boston, United States
Biotechnology Research
